Quality Improvement and Public Reporting in STEMI Care

Dan D Nguyen; Jacob A Doll

doi:10.1016/j.iccl.2021.03.009

Quality Improvement and Public Reporting in STEMI Care

Interv Cardiol Clin. 2021 Jul;10(3):391-400. doi: 10.1016/j.iccl.2021.03.009.

Authors

Dan D Nguyen¹, Jacob A Doll²

Affiliations

¹ Division of Cardiology, Department of Medicine, University of Washington, 1959 NE Pacific Street, Seattle, WA 98195, USA.
² Division of Cardiology, Department of Medicine, University of Washington, 1959 NE Pacific Street, Seattle, WA 98195, USA; VA Puget Sound Health Care System, 1660 S Columbian Way, Seattle, WA 98108, USA. Electronic address: jdoll@uw.edu.

PMID: 34053625
DOI: 10.1016/j.iccl.2021.03.009

Abstract

Mortality rates for patients with ST-segment elevation myocardial infarction (STEMI) remain high despite development of novel drugs and interventions over the past several decades. There is significant variability between hospitals in use of evidence-based treatments, and substantial opportunities exist to optimize care pathways and reduce disparities in care delivery. Quality improvement interventions implemented at local, regional, and national levels have improved care processes and patient outcomes. This article reviews evidence for quality improvement interventions along the spectrum of STEMI care, describes existing systems for quality measurement, and examines local and national policy interventions, with special attention to public reporting programs.

Keywords: Pay-for-performance; Public reporting; Quality improvement; Quality measures; STEMI.

Published by Elsevier Inc.

Publication types

Review

MeSH terms

Humans
Quality Improvement
ST Elevation Myocardial Infarction* / therapy